Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Studies of neuroimmune markers in Alzheimer's disease.

Singh VK.

Mol Neurobiol. 1994 Aug-Dec;9(1-3):73-81.

PMID:
7534089
2.

Antibodies against small heat-shock proteins in Alzheimer's disease as a part of natural human immune repertoire or activation of humoral response?

Papuć E, Krupski W, Kurys-Denis E, Rejdak K.

J Neural Transm (Vienna). 2016 Apr;123(4):455-61. doi: 10.1007/s00702-015-1477-2. Epub 2015 Nov 14.

3.

Immunoblot detection of antibodies to myelin basic protein in Alzheimer's disease patients.

Singh VK, Yang YY, Singh EA.

Neurosci Lett. 1992 Nov 23;147(1):25-8.

PMID:
1282691
4.

Interleukin-2 receptor in peripheral blood lymphocytes of Alzheimer's disease patients.

Ikeda T, Yamamoto K, Takahashi K, Kaneyuki H, Yamada M.

Acta Psychiatr Scand. 1991 Sep;84(3):262-5.

PMID:
1683096
5.

Can Antibodies Against Glial Derived Antigens be Early Biomarkers of Hippocampal Demyelination and Memory Loss in Alzheimer's Disease?

Papuć E, Kurys-Denis E, Krupski W, Tatara M, Rejdak K.

J Alzheimers Dis. 2015;48(1):115-21. doi: 10.3233/JAD-150309.

PMID:
26401933
6.

Systemic immune responses in Alzheimer's disease: in vitro mononuclear cell activation and cytokine production.

Pellicanò M, Bulati M, Buffa S, Barbagallo M, Di Prima A, Misiano G, Picone P, Di Carlo M, Nuzzo D, Candore G, Vasto S, Lio D, Caruso C, Colonna-Romano G.

J Alzheimers Dis. 2010;21(1):181-92. doi: 10.3233/JAD-2010-091714.

PMID:
20413861
8.

Peripheral blood mono-nuclear cells derived from Alzheimer's disease patients show elevated baseline levels of secreted cytokines but resist stimulation with β-amyloid peptide.

Rocha NP, Teixeira AL, Coelho FM, Caramelli P, Guimarães HC, Barbosa IG, da Silva TA, Mukhamedyarov MA, Zefirov AL, Rizvanov AA, Kiyasov AP, Vieira LB, Janka Z, Palotás A, Reis HJ.

Mol Cell Neurosci. 2012 Jan;49(1):77-84. doi: 10.1016/j.mcn.2011.09.005. Epub 2011 Sep 25.

PMID:
21971579
9.

Lymphocyte subset patterns and cytokine production in Alzheimer's disease patients.

Speciale L, Calabrese E, Saresella M, Tinelli C, Mariani C, Sanvito L, Longhi R, Ferrante P.

Neurobiol Aging. 2007 Aug;28(8):1163-9. Epub 2006 Jun 30.

PMID:
16814429
10.

Myelin basic protein associates with AβPP, Aβ1-42, and amyloid plaques in cortex of Alzheimer's disease brain.

Zhan X, Jickling GC, Ander BP, Stamova B, Liu D, Kao PF, Zelin MA, Jin LW, DeCarli C, Sharp FR.

J Alzheimers Dis. 2015;44(4):1213-29. doi: 10.3233/JAD-142013.

11.

Beta-amyloid peptides enhance the proliferative response of activated CD4CD28 lymphocytes from Alzheimer disease patients and from healthy elderly.

Jóźwik A, Landowski J, Bidzan L, Fülop T, Bryl E, Witkowski JM.

PLoS One. 2012;7(3):e33276. doi: 10.1371/journal.pone.0033276. Epub 2012 Mar 12.

12.

Systemic immune aberrations in Alzheimer's disease patients.

Bonotis K, Krikki E, Holeva V, Aggouridaki C, Costa V, Baloyannis S.

J Neuroimmunol. 2008 Jan;193(1-2):183-7. Epub 2007 Nov 26.

PMID:
18037502
13.

Blood and cerebrospinal fluid anomalies in brain ageing and Alzheimer's disease.

Soler Federsppiel BS, Karcher D, Lowenthal A.

Gerontology. 1987;33(3-4):193-6.

PMID:
2443427
14.

Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ42 Protofibrils in Alzheimer's Disease.

Söllvander S, Ekholm-Pettersson F, Brundin RM, Westman G, Kilander L, Paulie S, Lannfelt L, Sehlin D.

J Alzheimers Dis. 2015;48(1):63-72. doi: 10.3233/JAD-150236.

15.

Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.

Lueg G, Gross CC, Lohmann H, Johnen A, Kemmling A, Deppe M, Groger J, Minnerup J, Wiendl H, Meuth SG, Duning T.

Neurobiol Aging. 2015 Jan;36(1):81-9. doi: 10.1016/j.neurobiolaging.2014.08.008. Epub 2014 Aug 23.

PMID:
25277040
16.

Peripheral chemokine receptors, their ligands, cytokines and Alzheimer's disease.

Reale M, Iarlori C, Feliciani C, Gambi D.

J Alzheimers Dis. 2008 Jun;14(2):147-59.

PMID:
18560127
17.

Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies.

Dorothée G, Sarazin M, Aucouturier P.

Rev Neurol (Paris). 2013 Oct;169(10):715-8. doi: 10.1016/j.neurol.2013.07.023. Epub 2013 Sep 6. Review.

PMID:
24016465
18.

Differential neuroimmune markers to the onset of Alzheimer's disease neurodegeneration and dementia: autoantibodies to Abeta((25-35)) oligomers, S100b and neurotransmitters.

Gruden MA, Davidova TB, Malisauskas M, Sewell RD, Voskresenskaya NI, Wilhelm K, Elistratova EI, Sherstnev VV, Morozova-Roche LA.

J Neuroimmunol. 2007 May;186(1-2):181-92. Epub 2007 May 2.

PMID:
17477976
19.

Autoantibodies against amyloid and glial-derived antigens are increased in serum and cerebrospinal fluid of Lewy body-associated dementias.

Maetzler W, Berg D, Synofzik M, Brockmann K, Godau J, Melms A, Gasser T, Hörnig S, Langkamp M.

J Alzheimers Dis. 2011;26(1):171-9. doi: 10.3233/JAD-2011-110221.

PMID:
21593566
20.

Systemic immune system alterations in early stages of Alzheimer's disease.

Zhang R, Miller RG, Madison C, Jin X, Honrada R, Harris W, Katz J, Forshew DA, McGrath MS.

J Neuroimmunol. 2013 Mar 15;256(1-2):38-42. doi: 10.1016/j.jneuroim.2013.01.002. Epub 2013 Feb 4.

Supplemental Content

Support Center